Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Göbel

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Headache and Pain|September 25, 2024
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)Hartmut Göbel, Eugen Schlegel, Kathrin Jaeger, et al.
Pain|June 6, 2006
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre studyHartmut Göbel, Axel Heinze, Gerhard Reichel, et al.
Fortschritte Der Neurologie-Psychiatrie|June 12, 2024
[Acute Therapy of Migraine: What is new?]Axel Heinze, Katja Heinze-Kuhn, Hartmut Göbel, et al.
Der Internist|February 20, 2020
[Modern migraine therapy-interdisciplinary long-term care]Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
Pain and Therapy|May 4, 2021
Phenotype of Cluster Headache: Clinical Variability, Persisting Pain Between Attacks, and Comorbidities-An Observational Cohort Study in 825 PatientsCarl H Göbel, Sarah Karstedt, Axel Heinze, et al.
Pain and Therapy|February 25, 2021
Effect of Occipital Nerve Stimulation (ONS) on the Orbicularis Oculi Reflex Triggered by a Standardized Air Flow in Patients with Chronic Migraine-A Prospective, Randomized, Interventional StudyCarl H Göbel, Axel Heinze, Sarah Karstedt, et al.
Neurology International|March 26, 2025
The Impact of Biseasonal Time Changes on MigraineCarl H Göbel, Katja Heinze-Kuhn, Axel Heinze, et al.
European Neurology|December 5, 2002
Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraineSuzanne Christie, Hartmut Göbel, Valentin Mateos, et al.
Journal of Clinical Medicine|March 14, 2026
Neurologic Symptoms and Cerebrovascular Events During Atogepant Therapy: A Case Series with Contextual Comparison with a Non-Gepant-Treated Migraine CohortCarl H Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
Vaccines|February 26, 2025
Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine UsedCarl Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Headache and Pain|September 25, 2024
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)Hartmut Göbel, Eugen Schlegel, Kathrin Jaeger, et al.
Pain|June 6, 2006
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre studyHartmut Göbel, Axel Heinze, Gerhard Reichel, et al.
Fortschritte Der Neurologie-Psychiatrie|June 12, 2024
[Acute Therapy of Migraine: What is new?]Axel Heinze, Katja Heinze-Kuhn, Hartmut Göbel, et al.
Der Internist|February 20, 2020
[Modern migraine therapy-interdisciplinary long-term care]Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
Pain and Therapy|May 4, 2021
Phenotype of Cluster Headache: Clinical Variability, Persisting Pain Between Attacks, and Comorbidities-An Observational Cohort Study in 825 PatientsCarl H Göbel, Sarah Karstedt, Axel Heinze, et al.
Pain and Therapy|February 25, 2021
Effect of Occipital Nerve Stimulation (ONS) on the Orbicularis Oculi Reflex Triggered by a Standardized Air Flow in Patients with Chronic Migraine-A Prospective, Randomized, Interventional StudyCarl H Göbel, Axel Heinze, Sarah Karstedt, et al.
Neurology International|March 26, 2025
The Impact of Biseasonal Time Changes on MigraineCarl H Göbel, Katja Heinze-Kuhn, Axel Heinze, et al.
European Neurology|December 5, 2002
Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraineSuzanne Christie, Hartmut Göbel, Valentin Mateos, et al.
Journal of Clinical Medicine|March 14, 2026
Neurologic Symptoms and Cerebrovascular Events During Atogepant Therapy: A Case Series with Contextual Comparison with a Non-Gepant-Treated Migraine CohortCarl H Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
Vaccines|February 26, 2025
Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine UsedCarl Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
Pageof 6